Cargando…

Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia

The activation of c-Jun N-terminal kinase (JNK) plays an important role in stroke outcomes. Tryptanthrin-6-oxime (TRYP-Ox) is reported to have high affinity for JNK and anti-inflammatory activity and may be of interest as a promising neuroprotective agent. The aim of this study was to investigate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Plotnikov, Mark B., Chernysheva, Galina A., Smol’yakova, Vera I., Aliev, Oleg I., Anishchenko, Anna M., Ulyakhina, Olga A., Trofimova, Eugene S., Ligacheva, Anastasia A., Anfinogenova, Nina D., Osipenko, Anton N., Kovrizhina, Anastasia R., Khlebnikov, Andrei I., Schepetkin, Igor A., Drozd, Anastasia G., Plotnikov, Evgenii V., Atochin, Dmitriy N., Quinn, Mark T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457995/
https://www.ncbi.nlm.nih.gov/pubmed/37630972
http://dx.doi.org/10.3390/ph16081057
_version_ 1785097058550546432
author Plotnikov, Mark B.
Chernysheva, Galina A.
Smol’yakova, Vera I.
Aliev, Oleg I.
Anishchenko, Anna M.
Ulyakhina, Olga A.
Trofimova, Eugene S.
Ligacheva, Anastasia A.
Anfinogenova, Nina D.
Osipenko, Anton N.
Kovrizhina, Anastasia R.
Khlebnikov, Andrei I.
Schepetkin, Igor A.
Drozd, Anastasia G.
Plotnikov, Evgenii V.
Atochin, Dmitriy N.
Quinn, Mark T.
author_facet Plotnikov, Mark B.
Chernysheva, Galina A.
Smol’yakova, Vera I.
Aliev, Oleg I.
Anishchenko, Anna M.
Ulyakhina, Olga A.
Trofimova, Eugene S.
Ligacheva, Anastasia A.
Anfinogenova, Nina D.
Osipenko, Anton N.
Kovrizhina, Anastasia R.
Khlebnikov, Andrei I.
Schepetkin, Igor A.
Drozd, Anastasia G.
Plotnikov, Evgenii V.
Atochin, Dmitriy N.
Quinn, Mark T.
author_sort Plotnikov, Mark B.
collection PubMed
description The activation of c-Jun N-terminal kinase (JNK) plays an important role in stroke outcomes. Tryptanthrin-6-oxime (TRYP-Ox) is reported to have high affinity for JNK and anti-inflammatory activity and may be of interest as a promising neuroprotective agent. The aim of this study was to investigate the neuroprotective effects of TRYP-Ox in a rat model of transient focal cerebral ischemia (FCI), which involved intraluminal occlusion of the left middle cerebral artery (MCA) for 1 h. Animals in the experimental group were administered intraperitoneal injections of TRYP-Ox 30 min before reperfusion and 23 and 47 h after FCI. Neurological status was assessed 4, 24, and 48 h following FCI onset. Treatment with 5 and 10 mg/kg of TRYP-Ox decreased mean scores of neurological deficits by 35–49 and 46–67% at 24 and 48 h, respectively. At these doses, TRYP-Ox decreased the infarction size by 28–31% at 48 h after FCI. TRYP-Ox (10 mg/kg) reduced the content of interleukin (IL) 1β and tumor necrosis factor (TNF) in the ischemic core area of the MCA region by 33% and 38%, respectively, and attenuated cerebral edema by 11% in the left hemisphere, which was affected by infarction, and by 6% in the right, contralateral hemisphere 24 h after FCI. TRYP-Ox reduced c-Jun phosphorylation in the MCA pool at 1 h after reperfusion. TRYP-Ox was predicted to have high blood–brain barrier permeability using various calculated descriptors and binary classification trees. Indeed, reactive oxidant production was significantly lower in the brain homogenates from rats treated with TRYP-Ox versus that in control animals. Our data suggest that the neuroprotective activity of TRYP-Ox may be due to the ability of this compound to inhibit JNK and exhibit anti-inflammatory and antioxidant activity. Thus, TRYP-Ox may be considered a promising neuroprotective agent that potentially could be used for the development of new treatment strategies in cerebral ischemia.
format Online
Article
Text
id pubmed-10457995
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104579952023-08-27 Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia Plotnikov, Mark B. Chernysheva, Galina A. Smol’yakova, Vera I. Aliev, Oleg I. Anishchenko, Anna M. Ulyakhina, Olga A. Trofimova, Eugene S. Ligacheva, Anastasia A. Anfinogenova, Nina D. Osipenko, Anton N. Kovrizhina, Anastasia R. Khlebnikov, Andrei I. Schepetkin, Igor A. Drozd, Anastasia G. Plotnikov, Evgenii V. Atochin, Dmitriy N. Quinn, Mark T. Pharmaceuticals (Basel) Article The activation of c-Jun N-terminal kinase (JNK) plays an important role in stroke outcomes. Tryptanthrin-6-oxime (TRYP-Ox) is reported to have high affinity for JNK and anti-inflammatory activity and may be of interest as a promising neuroprotective agent. The aim of this study was to investigate the neuroprotective effects of TRYP-Ox in a rat model of transient focal cerebral ischemia (FCI), which involved intraluminal occlusion of the left middle cerebral artery (MCA) for 1 h. Animals in the experimental group were administered intraperitoneal injections of TRYP-Ox 30 min before reperfusion and 23 and 47 h after FCI. Neurological status was assessed 4, 24, and 48 h following FCI onset. Treatment with 5 and 10 mg/kg of TRYP-Ox decreased mean scores of neurological deficits by 35–49 and 46–67% at 24 and 48 h, respectively. At these doses, TRYP-Ox decreased the infarction size by 28–31% at 48 h after FCI. TRYP-Ox (10 mg/kg) reduced the content of interleukin (IL) 1β and tumor necrosis factor (TNF) in the ischemic core area of the MCA region by 33% and 38%, respectively, and attenuated cerebral edema by 11% in the left hemisphere, which was affected by infarction, and by 6% in the right, contralateral hemisphere 24 h after FCI. TRYP-Ox reduced c-Jun phosphorylation in the MCA pool at 1 h after reperfusion. TRYP-Ox was predicted to have high blood–brain barrier permeability using various calculated descriptors and binary classification trees. Indeed, reactive oxidant production was significantly lower in the brain homogenates from rats treated with TRYP-Ox versus that in control animals. Our data suggest that the neuroprotective activity of TRYP-Ox may be due to the ability of this compound to inhibit JNK and exhibit anti-inflammatory and antioxidant activity. Thus, TRYP-Ox may be considered a promising neuroprotective agent that potentially could be used for the development of new treatment strategies in cerebral ischemia. MDPI 2023-07-25 /pmc/articles/PMC10457995/ /pubmed/37630972 http://dx.doi.org/10.3390/ph16081057 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Plotnikov, Mark B.
Chernysheva, Galina A.
Smol’yakova, Vera I.
Aliev, Oleg I.
Anishchenko, Anna M.
Ulyakhina, Olga A.
Trofimova, Eugene S.
Ligacheva, Anastasia A.
Anfinogenova, Nina D.
Osipenko, Anton N.
Kovrizhina, Anastasia R.
Khlebnikov, Andrei I.
Schepetkin, Igor A.
Drozd, Anastasia G.
Plotnikov, Evgenii V.
Atochin, Dmitriy N.
Quinn, Mark T.
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
title Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
title_full Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
title_fullStr Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
title_full_unstemmed Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
title_short Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
title_sort neuroprotective effects of tryptanthrin-6-oxime in a rat model of transient focal cerebral ischemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457995/
https://www.ncbi.nlm.nih.gov/pubmed/37630972
http://dx.doi.org/10.3390/ph16081057
work_keys_str_mv AT plotnikovmarkb neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT chernyshevagalinaa neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT smolyakovaverai neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT alievolegi neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT anishchenkoannam neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT ulyakhinaolgaa neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT trofimovaeugenes neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT ligachevaanastasiaa neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT anfinogenovaninad neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT osipenkoantonn neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT kovrizhinaanastasiar neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT khlebnikovandreii neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT schepetkinigora neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT drozdanastasiag neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT plotnikovevgeniiv neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT atochindmitriyn neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia
AT quinnmarkt neuroprotectiveeffectsoftryptanthrin6oximeinaratmodeloftransientfocalcerebralischemia